Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SARS-CoV-2 Nucleocapsid anticorps

SARS-CoV-2 N Reactivité: SARS Coronavirus-2 (SARS-CoV-2), Virus ELISA, WB Hôte: Souris Monoclonal 1C7 unconjugated
N° du produit ABIN6952435
  • Antigène Voir toutes SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Anticorps
    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
    Reactivité
    • 59
    • 11
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    SARS Coronavirus-2 (SARS-CoV-2), Virus
    Hôte
    • 30
    • 16
    • 15
    • 4
    • 1
    • 1
    Souris
    Clonalité
    • 51
    • 10
    • 5
    Monoclonal
    Conjugué
    • 49
    • 9
    • 5
    • 2
    • 1
    Cet anticorp SARS-CoV-2 Nucleocapsid est non-conjugé
    Application
    • 56
    • 25
    • 11
    • 7
    • 6
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Western Blotting (WB)
    Purification
    Purified by Protein G.
    Immunogène
    Recombinant SARS-CoV-2 N protein (His-tag)
    Clone
    1C7
    Isotype
    IgG2b
  • Indications d'application
    WB 1:300-1000
    ELISA 1:500-1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M PBS( pH 7.4) with 0.1 % Proclin300.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20 °C
    Date de péremption
    12 months
  • Sperber, Sutter, Müller, Müller, Schwarzer: "The Bovine Seminal Plasma Protein PDC-109 Possesses Pan-Antiviral Activity." dans: Viruses, Vol. 14, Issue 9, (2022) (PubMed).

    Le-Trilling, Mennerich, Schuler, Sakson, Lill, Kasarla, Kopczynski, Loroch, Flores-Martinez, Katschinski, Wohlgemuth, Gunzer, Meyer, Phapale, Dittmer, Sickmann, Trilling: "Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro." dans: BMC biology, Vol. 20, Issue 1, pp. 264, (2022) (PubMed).

    Wenzek, Steinbach, Wirsdörfer, Sutter, Boehme, Geffers, Klopfleisch, Bruder, Jendrossek, Buer, Westendorf, Knuschke: "CD47 restricts antiviral function of alveolar macrophages during influenza virus infection." dans: iScience, Vol. 25, Issue 12, pp. 105540, (2022) (PubMed).

    Krempe, Schöler, Katschinski, Herrmann, Anastasiou, Elsner, Ross, Scholz, Dittmer, Miethe, Le-Trilling, Trilling: "A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19." dans: iScience, Vol. 24, Issue 10, pp. 103194, (2021) (PubMed).

    Schöler, Le-Trilling, Eilbrecht, Mennerich, Anastasiou, Krawczyk, Herrmann, Dittmer, Trilling: "A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds." dans: Frontiers in immunology, Vol. 11, pp. 573526, (2020) (PubMed).

    Chen, Juric, Cosgrove, Bowman, Fitzpatrick, Schoech, Clark, Coop: "Allele frequency dynamics in a pedigreed natural population." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Issue 6, pp. 2158-2164, (2019) (PubMed).

  • Antigène
    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
    Autre désignation
    SARS-CoV-2 N protein (SARS-CoV-2 N Produits)
    Synonymes
    anticorps nucleocapsid phosphoprotein, anticorps N
    Classe de substances
    Viral Protein
    UniProt
    P0DTC9
Vous êtes ici:
Support technique